| EDD | effective drug duration; electron dense deposit; end-diastolic dimension; esophageal detection devic... |
|---|---|
| EEEP | end-expiratory esophageal pressure |
| EGTA | esophageal gastric tube airway; ethyleneglycol-bis-(b-aminoethylether)-N,N,N',N'-tetraacetic acid |
| EHH | esophageal hiatal hernia |
| EMD | electromechanical dissociation; emergency medical dispacher; emergency medical doctor; Emery-Dreifus... |
| ureteral neoplasms | Neoplasms or tumours of the ureter. Haematuria, which occurs in 75% of patients with ureteral carcinoma, is the most common presenting symptom. The most common site for the occurrence of a ureteral tumour is in the lower third of the ureter, with a lesser incidence higher up. (12 Dec 1998) |
|---|---|
| urethral neoplasms | Neoplasms or tumours of the urethra. This condition is relatively uncommon and is the only cancer of the urinary system that has a higher incidence rate in females than males. Squamous cell carcinoma is the most frequent histologic type. (12 Dec 1998) |
| urogenital neoplasms | Neoplasms of the urogenital tract. (12 Dec 1998) |
| urologic neoplasms | Neoplasms of the urinary tract in both male and female. It does not include the male genitalia for which urogenital neoplasms is used for general discussions of neoplasms of both the urinary tract and the genitalia. (12 Dec 1998) |
| uterine neoplasms | Neoplasms of the uterus. (12 Dec 1998) |
| laryngeal neoplasms | Cancers or tumours of the larynx or any of its parts: the glottis, epiglottis, laryngeal cartilages, laryngeal muscles, and vocal cords. (12 Dec 1998) |
| liver neoplasms, experimental | Experimentally induced tumours of the liver. (12 Dec 1998) |